<DOC>
	<DOCNO>NCT00758433</DOCNO>
	<brief_summary>To evaluate tolerability two different strength Civamide Patch ( 0.0075 % 0.0150 % ) compare placebo patch healthy adult volunteer . To assess pharmacokinetics civamide determine systemic absorption drug civamide patch subset study subject .</brief_summary>
	<brief_title>Civamide Patch Safety , Tolerability PK Study</brief_title>
	<detailed_description>This double-blind , randomize study tolerability two different strength Civamide Patch compare placebo patch . The study consist Screening Period ( Days -21 Day 1 ) , one week Treatment Period ( Days 1-8 ) follow-up telephone call subject Day 10 . Pharmacokinetics assess relative dosing Day 1 , Day 2 , Day 8 subset subject . Subjects also rate sting burn sensation application site Treatment Period . Twenty-four ( 24 ) hour last patch application , subject return study site Day 8 . The treatment area evaluate Study Physician . Subjects complete Subject 's Global Rating Stinging Burning Sensation Subject 's Global Rating Tolerability .</detailed_description>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Inclusion Criteria 1 . Subject voluntarily agree participate study sign IRB approve informed consent prior perform screen procedure . 2 . Subject healthy , determine prestudy medical evaluation medical history , physical examination treatment area , vital sign ) . 3 . Males females 18 60 year age , inclusive . 4 . Nonpregnant , nonlactating female childbearing potential agree use medically acceptable form birth control ( abstinence , hormonal contraceptive , diaphragm spermicide , condom spermicide , intrauterine device ) Screening Day 10 followup female nonchildbearing potential ( surgically sterile [ hysterectomy bilateral tubal ligation ] postmenopausal â‰¥ 1 year ) . 5 . Subject blood pressure read low equal 144/92 mmHg . 6 . Subject oral temperature read low 99.6F . 7 . Subjects must area skin abdomen without active skin disease , infection , severe erythema , compromise integrity skin near intend treatment area . 8 . The subject visual motor impairment make difficult complete VAS scale apply patch . 9 . Nonsmoker determine history past year . 10 . Subject body mass index ( BMI ) 18.5 30.5 kg/m2 , pk subset . 11 . Subject willing able cooperate extent require protocol . 1 . Subject know allergy hypersensitivity ) Civamide , capsicum , capsaicincontaining product , b ) ingredient patch c ) adhesives . 2 . Presence cutaneous abnormality condition may adversely impact application test patch . 3 . History frequent headache painful condition within past 30 day require expected require chronic use prescription counter pain relief medication , non steroidal antiinflammatory agent , include COX2 inhibitor , systemic opiate derivative , acetaminophen , prior Day 1 within 48 hour prior Day 1 . 4 . Use alcohol alcoholcontaining food , medication beverage within 24 hour prior Day 1 completion Study Day 10 . 5 . Topical use moisturizer medicate product near treatment area within 48 hour Day 1 completion Study Day 10 . 6 . Topical use capsaicincontaining product 60 day prior Day 1 completion Study Day 10 . 7 . Subject history alcohol and/or drug abuse within two year study entry . 8 . Female subject breastfeed . 9 . Unwilling maintain usual consumption caffeine contain beverage within 24 hour prior Day 1 completion Day 8 . 10 . Subject unwilling abstain vigorous exercise 48 hour prior Day 1 completion Study Day 10 . 11 . Subject unwilling abstain swimming , bath prolong direct stream water shower Day 1 Day 8 12 . Use investigational drug within 30 day prior Day 1 . 13 . Donation blood ( &gt; 250 ml ) blood product within 2 month ( 56 day ) prior Day 1 . 14 . Ingestion capsaicincontaining food 24 hour Day 1 study . 15 . If reason subject deem healthy investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Adverse Events</keyword>
	<keyword>Erythema Rating</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Civamide</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Pain</keyword>
	<keyword>Patch</keyword>
</DOC>